CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 30.23
  • -1.37-4.34%
Market Closed Nov 12 15:00 CST
11.08BMarket Cap-14219P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chongqing Genrix Biopharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
12.48M
--
+196972.94%
Net Income
--
-184.41M
--
-2.40%
Analyst Rating
Strong Buy

Nov 12, 2024

Chongqing Genrix Biopharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 280.750M --
-- 2024/FY -- / 61.000M --
-- 2023/FY 1.212M / 50.000K --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 280.750M--
--2024/FY-- / 61.000M--
--2023/FY1.212M / 50.000K--
--------
--------

Unlock Free Earnings Estimates

Chongqing Genrix Biopharmaceutical Earnings Reports

  • Zhixiang Jintai: Third Quarter Report 2024

    Oct 31 00:00

  • Third Quarter Report 2024

    Oct 31 00:00

  • 2024 Semi-Annual Report Summary

    Aug 31 00:00

  • 2024 Semi-Annual Report

    Aug 31 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Strong Buy

      76.92%

    • Buy

      23.08%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data